Japan: A new study published in JAMA Network Open found that women with a history of gestational diabetes who fed at least 80% breast milk to their newborns had more favorable lipid profiles and cardiometabolic markers in the first three months after delivery. 

The findings come from a prospective cohort study led by Harumi Kanzawa, Department of Health Sciences, Graduate School of Biomedical Sciences, Nagasaki University School of Medicine, Nagasaki, Japan, and colleagues. The researchers examined whether the intensity of breastfeeding was associated with lipid metabolism during the early postpartum period, when women with previous gestational diabetes remain at increased risk of cardiometabolic abnormalities.
The study included 470 Japanese women with prior gestational diabetes who underwent metabolic assessments between 6 and 9 weeks after delivery at a tertiary medical center. Participants were evaluated between December 2014 and November 2020, with statistical analyses conducted from April 2024 through June 2026.
Breastfeeding intensity was assessed using a validated six-level scale. Women who provided at least 80% of their infant’s milk as breast milk were classified as practicing high-intensity breastfeeding (HIB). Fasting lipid concentrations were assessed, and dyslipidemia was defined according to Japan Atherosclerosis Society criteria. The researchers also accounted for clinical characteristics and insulin sensitivity, measured using the Matsuda index.
Among the participants, 369 women (79%) practiced HIB. The analysis showed notable differences in lipid profiles between women practicing HIB and those who did not.
Key findings:
  • Mean triglyceride levels were lower among women practicing HIB than among those who did not (67.2 vs 116.1 mg/dL).
  • Mean HDL cholesterol levels were higher with HIB (73.9 vs 63.0 mg/dL).
  • The LDL-C to HDL-C ratio was lower among women practicing HIB (1.8 vs 2.3).
  • HIB was associated with substantially lower odds of hypertriglyceridemia (adjusted odds ratio [AOR], 0.25).
  • Women practicing HIB also had lower odds of an elevated LDL-C to HDL-C ratio (AOR, 0.27).
  • The associations remained statistically significant even after accounting for insulin sensitivity.
The researchers noted limitations, including self-reported breastfeeding data, lack of pregnancy lipid measurements and information on previous pregnancies and neonatal intensive care admissions. As an observational, single-center study, causality cannot be established, residual confounding is possible, and the findings may not be generalizable to other populations. The durability of the observed lipid associations also remains unknown.
Overall, the study found that higher-intensity breastfeeding was associated with a more favorable lipid profile shortly after delivery among women with previous gestational diabetes, particularly reflected by the LDL-C to HDL-C ratio. The authors noted that structured lactation support may have implications for postpartum cardiometabolic care, while further research is needed to determine whether these associations persist and translate into long-term cardiovascular benefits.
Reference:
Kanzawa H, Yasuhi I, Yamashita H, Yatsuhashi H. Breastfeeding Intensity and Early Postpartum Lipid Profiles Among Women With Prior Gestational Diabetes. JAMA Netw Open. 2026;9(8):e2631833. doi:10.1001/jamanetworkopen.2026.31833
Tags:    
Article Source : JAMA Network Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .